| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |